Lifecore Biomedical, Inc. (LFCR)

Lifecore Biomedical Balance Sheet

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 24, 2024	May 26, 2024	May 28, 2023	May 29, 2022	May 30, 2021	May 31, 2020
Cash & Equivalents	9.46	8.46	19.09	0.99	1.16	0.36
Cash & Short-Term Investments	9.46	8.46	19.09	0.99	1.16	0.36
Cash Growth	193.54%	-55.68%	1826.44%	-14.50%	221.94%	-66.67%
Accounts Receivable	30.3	31.15	29.02	38.31	41.43	76.21
Receivables	30.3	31.15	29.02	38.31	41.43	76.21
Inventory	39.21	39.98	40.84	36	63.08	66.31
Prepaid Expenses	2.89	1.44	4.02	1.05	4.54	14.23
Other Current Assets	-	-	0.9	40.31	38.12	-
Total Current Assets	81.86	81.03	93.88	116.67	148.32	157.11
Property, Plant & Equipment	152.88	151.04	138.67	124.22	137.38	217.66
Long-Term Investments	-	-	-	-	-	56.9
Goodwill	13.88	13.88	13.88	13.88	33.92	69.39
Other Intangible Assets	4.2	4.2	4.2	4.2	25.63	38.11
Long-Term Deferred Charges	-	-	1.4	-	-	-
Other Long-Term Assets	2.57	3.81	1.52	15.73	157.67	2.16
Total Assets	255.39	253.96	253.55	274.7	502.92	541.31
Accounts Payable	14.97	16.33	22.1	12.95	16.3	51.65
Accrued Expenses	11.48	15.52	11.29	15.42	11.71	19.01
Short-Term Debt	-	-	-	40	29	77.4
Current Portion of Long-Term Debt	0.77	0.77	0.58	98.18	-	11.55
Current Portion of Leases	4.12	4.13	1.27	4.37	1.6	4.42
Current Unearned Revenue	3.95	2.11	4.06	0.92	0.64	0.35
Other Current Liabilities	-	-	-	4.74	42.64	-
Total Current Liabilities	35.29	38.87	39.29	176.58	101.89	164.39
Long-Term Debt	119.03	120.51	101.07	-	166.64	104.94
Long-Term Leases	7.42	4.94	9.71	7.66	20.36	26.38
Long-Term Unearned Revenue	5.06	5	2.94	-	-	-
Long-Term Deferred Tax Liabilities	0.55	0.54	0.38	0.13	6.14	13.59
Other Long-Term Liabilities	28.28	30.19	65.07	2.52	5.12	0.97
Total Liabilities	195.63	200.06	218.46	186.88	300.14	310.27
Common Stock	0.04	0.03	0.03	0.03	0.03	0.03
Additional Paid-In Capital	206.87	177.81	174.28	167.35	165.53	162.58
Retained Earnings	-191.46	-166.52	-178.54	-78.97	38.58	71.25
Comprehensive Income & Other	-	-	-	-0.59	-1.36	-2.81
Total Common Equity	15.45	11.32	-4.23	87.82	202.78	231.04
Shareholders' Equity	59.76	53.9	35.09	87.82	202.78	231.04
Total Liabilities & Equity	255.39	253.96	253.55	274.7	502.92	541.31
Total Debt	131.34	130.36	112.62	150.2	217.6	224.7
Net Cash (Debt)	-121.89	-121.9	-93.53	-149.21	-216.44	-224.34
Net Cash Per Share	-3.86	-3.33	-3.12	-5.06	-7.39	-7.69
Filing Date Shares Outstanding	37.03	30.9	30.55	29.6	29.46	29.24
Total Common Shares Outstanding	36.98	30.56	30.32	29.51	29.33	29.22
Working Capital	46.57	42.16	54.59	-59.91	46.43	-7.28
Book Value Per Share	0.42	0.37	-0.14	2.98	6.91	7.91
Tangible Book Value	-2.63	-6.77	-22.31	69.74	143.24	123.55
Tangible Book Value Per Share	-0.07	-0.22	-0.74	2.36	4.88	4.23
Land	3.74	3.74	3.74	3.71	3.67	13.21
Buildings	63.8	58.77	56.79	54.56	47.88	85.69
Machinery	72.8	70.93	77.36	72.55	74.35	149.26
Construction In Progress	64.61	61.39	45.59	26.89	31.38	28.45
Leasehold Improvements	-	-	4.02	4.02	6.47	6.83

Source: S&P Capital IQ. Standard template. Financial Sources.